Evaluation and management of brain metastatic patients with high-risk gestational trophoblastic tumors |
| |
Authors: | F. Ghaemmaghami,N. Behtash,N. Memarpour,K. Soleimani,P. Hanjani&dagger ,& F. A. Hashemi&Dagger |
| |
Affiliation: | Department of Gynecology and Oncology, Tehran University of Medical Sciences, Tehran, Iran. ftghaemmagh@yahoo.com |
| |
Abstract: | A retrospective study to evaluate the characteristics of brain metastatic patients with gestational trophoblastic tumors (GTT) and to analyze the results of treatment has been performed. During 1996-2001, 40 patients with metastatic GTT were diagnosed at Vali-e-Asr Hospital, Tehran, Iran. Of them, nine with brain metastases, which were documented with the help of computed tomography scan, were evaluated retrospectively. Eight patients received EMA-EP regimen (etoposide, methotrexate, actinomycin, etoposide, and cisplatinum) and one received EMA-CO (etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristin). All cases received whole brain irradiation therapy concurrently. The median age of the patients at diagnosis was 30 years (range: 17-53). Six of them were of early group (five with symptoms of central nervous system and one was detected during workup) and three were of late group (relapsed group). Five (56%) patients responded to treatment and four (44%) were deceased (three of them belonged to late group). It seems that multi-agent chemotherapy (EMA-EP) concurrently with whole brain irradiation results in acceptable survival rates in GTT patients with brain metastases. |
| |
Keywords: | brain metastatic GTT choriocarcinoma EMA-EP regimen multi-agent chemotherapy |
|
|